Andreas Schmocker, Lumigbo

Medtech, EPF Lausanne

The patented platform technology consists of light activated materials to build up implants or tissue replacement inside the body.


Lumigobo’s patented platform technology (5 PCT patents) consists of light activated materials to build up implants or tissue replacement inside the body. They place cm-sized implants through a 300 μm sized catheter or needle in a biocompatible, controllable manner using light illumination.